GLP-1 by the numbers 8-10% of US adults already on a GLP-1 30-35% of consumers say theyre interested (PwC) 30 million projected global users by 2030 $126-$150 billion projected size of the obesity drug market by 2030 Household snack spend falls 5-11% within six months of a GLP-1 start Reformulation or retreat Not all players are on the defensive
Obesity-related hypogonadism is one of the most common reversible causes of low testosterone that I see in practice
Total cost varies by location and brand choices, but expect roughly $75-$120 per week for one person
Given the intractable pediatric obesity epidemic and associated rise in type 2 diabetes in youth, made worse by the COVID-19 pandemic related shutdowns and disruptions in opportunities for exercise and play in youth, this new class of medications will certainly benefit children with morbid obesity and type 2 diabetes
In addition to conventional GLP-1 agonists like Ozempic and Wegovy, which only target the GLP-1 receptor, she is also researching medications like Mounjaro, which also targets the GIP receptor, and even the just-released retatrutide, which targets the glucagon receptor in addition to GLP-1 and GIP receptors
